EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions

NCT01435031 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)
Chronic Total Occlusion (CTO)

Interventions

DEVICE: CTO Treatment Device

Sponsor

Abbott Medical Devices